Back to top
more

Sabra Healthcare REIT (SBRA)

(Delayed Data from NSDQ)

$18.18 USD

18.18
2,300,525

-0.06 (-0.33%)

Updated Nov 15, 2024 03:59 PM ET

After-Market: $18.16 -0.02 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.78% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

City Holding (CHCO) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

City Holding (CHCO) delivered earnings and revenue surprises of 5.21% and 3.07%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

MPW Stock Surges 33.9% in a Month: Should You Buy Now or Wait?

by Zacks Equity Research

Medical Properties rides on interest rate cut, control over its real estate from Steward and balance-sheet strengthening efforts despite operator concentration.

Ventas Secures Agreements With Kindred & ScionHealth for 23 LTACs

by Zacks Equity Research

To improve patient care facilities, VTR announces reaching an agreement with Kindred and ScionHealth regarding 23 long-term acute care hospitals.

Medical Properties Resumes Control of its Real Estate From Steward

by Zacks Equity Research

MPW settles with the Steward Health Care System by reinstating control over its real estate to safeguard the essential operations of these facilities.

PINE vs. SBRA: Which Stock Is the Better Value Option?

by Zacks Equity Research

PINE vs. SBRA: Which Stock Is the Better Value Option?

Medical Properties (MPW) Disposes of 11 Facilities to UCHealth

by Zacks Equity Research

In line with its capital recycling strategy, Medical Properties (MPW) sells 11 facilities in Colorado to University of Colorado Health for $86 million.

Sabra (SBRA) Reports Q2 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sabra Healthcare (SBRA) Q2 FFO and Revenues Top Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.86% and 2.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Sabra (SBRA) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

by Zacks Equity Research

Get a deeper insight into the potential performance of Sabra (SBRA) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

DiamondRock Hospitality (DRH) Beats Q2 FFO and Revenue Estimates

by Zacks Equity Research

DiamondRock Hospitality (DRH) delivered FFO and revenue surprises of 6.25% and 2.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Four Corners Property Trust (FCPT) Matches Q2 FFO Estimates

by Zacks Equity Research

Four Corners Property (FCPT) delivered FFO and revenue surprises of 0% and 0.81%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, Sabra (SBRA) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS

by Zacks Equity Research

Evaluate the expected performance of Sabra (SBRA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of -2.94% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Sabra (SBRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Alexander's (ALX) Lags Q4 FFO Estimates

by Zacks Equity Research

Alexander's (ALX) delivered FFO and revenue surprises of -16.13% and 13.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for KBWY

Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Sabra (SBRA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Lamar Advertising (LAMR) Beats Q3 FFO Estimates

by Zacks Equity Research

Lamar (LAMR) delivered FFO and revenue surprises of 6.81% and 0.16%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for KBWY

Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Sabra Healthcare (SBRA) Q2 FFO Meet Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 0% and 1.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?